OTCMKTS:IAGX Imagenetix (IAGX) Stock Price, News & Analysis → why 99.94% won’t make you money (From Prosper Trading Academy) (Ad) Free IAGX Stock Alerts $0.0002 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.0001▼$0.0002VolumeN/AAverage VolumeN/AMarket Capitalization$5,714.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Imagenetix alerts: Email Address Ad Prosper Trading Academywhy 99.94% won’t make you moneyI believe there's only 5-7 stocks that you should trade in 2024. But here's the catch…because there's always a catch in life. You NEED to use a specific system when you trade them.Click here to download my options trading cheat sheet (5-7 stocks inside here) About ImagenetixImagenetix, Inc. develops, formulates, and markets proprietary and natural based nutritional supplements, and over-the-counter topical creams and skin care products. Its primary product is Celadrin, a product formulation for joint health. The company also licenses its intellectual property to third parties. Imagenetix, Inc. markets its products through various channels of distribution, including direct and mass marketing companies, nutritional newsletters, and medical and nutritional oriented professionals; medical newsletters; and direct response radio and television. The company was founded in 1996 and is based in San Diego, California.Read More IAGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IAGX Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive IAGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imagenetix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/18/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:IAGX CUSIPN/A CIKN/A Webwww.imagenetix.net Phone(858) 674-8455Fax858-674-8460Employees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares28,570,000Free FloatN/AMarket Cap$5,714.00 OptionableNot Optionable Beta1.20 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Lowell W. Giffhorn (Age 77)CFO & Secretary Comp: $64.61kMr. William P. Spencer (Age 71)Chief Technology Officer & Director Comp: $105.73kMr. Decky GoodrichCEO, President & DirectorKey CompetitorsBohai Pharmaceuticals GroupOTCMKTS:BOPHEvelo BiosciencesNASDAQ:EVLOParnell PharmaceuticalsOTCMKTS:PARNFQ BioMedOTCMKTS:QBIOMusclePharmOTCMKTS:MSLPView All Competitors IAGX Stock Analysis - Frequently Asked Questions How have IAGX shares performed in 2024? Imagenetix's stock was trading at $0.0002 at the beginning of the year. Since then, IAGX stock has increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here. How do I buy shares of Imagenetix? Shares of IAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IAGX) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that...Porter & Company | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imagenetix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imagenetix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.